Mesoblast's Partner Receives Full Approval in Japan; Commercial Launch Ahead
Mesoblast's Japanese partner, JCR Pharmaceuticals, has received full approval from the Japanese Ministry of Health, Labour and Welfare for its...
283 Views
Major Milestone Ahead for Mesoblast as Japanese Partner Moves Closer to Market with JR-031
Mesoblast's Japanese partner, JCR Pharmaceuticals, has announced that its acute Graft versus Host Disease, or aGvHD, product, JR-031, was...
283 Views
Taxing Times For Australia
The Government's release of Re:think, its tax discussion paper, is a welcome development, designed to kick-start the conversation with the...
5.8k Views